Overall Fundamental outlook

* GRANULES makes the list of companies with the best fundamentals at present.

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

Revenues for GRANULES are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 1.80100
forwardPE 18.57774
debtToEquity 29.73500
earningsGrowth 0.31100
revenueGrowth 0.24500
grossMargins 0.65174
operatingMargins 0.19497
trailingEps 24.49000
forwardEps 37.73333

GRANULES's current ratio is 1.801, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as GRANULES should not face any issues meeting its short-term liabilities with available resources.
Granules India Limited's Forward PE ratio suggests the stock price is reasonable in relation to earnings. It's not overpriced, providing room for future growth, making the stock a potentially valuable investment for those seeking long-term gains.
GRANULES's low Debt-to-Equity ratio demonstrates that the company maintains a healthy balance between equity and debt, avoiding over-leverage. This suggests a low-risk financial profile, giving investors confidence in the company's stability and ability to manage its financial commitments.
With positive earnings and revenue growth, GRANULES is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
GRANULES's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that GRANULES is likely to outperform its previous year's financial performance.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

Over time, price projections for GRANULES have risen steadily, pointing to growing optimism among analysts about the company's future. This upward trend suggests a positive outlook for GRANULES's continued growth.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


The recent buy bias from analysts suggests GRANULES is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, GRANULES appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.